Defymed

Defymed

UN PROJET À NOUS SOUMETTRE ?

Discutons-en

Defymed

Defymed® is a company that aims to develop and market implantable bio-artificial medical devices for diverse therapeutic applications.

Defymed® is a company that develops implantable bio-artificial medical devices for diverse therapeutic applications, with a first focus on type 1 diabetes. The blockbuster product is a bio-artificial pancreas, named MAILPAN® (MAcro-encapsulation of PANcreatic Islets). Defymed® is a spin-off of the CeeD (Centre europeen d’etude du Diabete) which has been working on an innovative concept of a bio-artificial pancreas since 1996. This work of conception of a macro-encapsulation device of insulin-secretory cells was carried out in collaboration with STATICE and the CTTM (Centre de Transfert de Technologies du Mans) in the frame of two European programs: 4th PCRD (1996-2000) and 6th PCRD (2004-2007).

"Conformément à la loi "informatique et libertés" du 6 janvier 1978 modifiée, vous bénéficiez d’un droit d’accès et de rectification aux informations qui vous concernent. Si vous souhaitez exercer ce droit et obtenir communication des informations vous concernant, veuillez vous adresser à contact@oxygen-rp.com"